Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON26789Recruiting
Open-label, single-arm trial of midazolam, propofol, sufentanil, pancuronium, ranitidine and 3 more in Cardiovascular Malformation (CVM), sponsored by Erasmus MC. Primary endpoints: Population pharmacokinetics of routine perioperative drugs and Relationship between pharmacokinetics and clinical parameters. Started Jul 2012; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON26789.